CD14 and brucellosis: Specifically, inchronic brucellosis patients, high percentage of CD14+/CD80+ monocytes in PHAand PHA plus E. coli LPS cultures might compensate for an ineffectualCD4+ T-cell response characterizing these form of disease [17–21].